Wire Stories

Kaseya Unveils Its Major Event Line-Up for 2023

With five large customer-centric conferences and multiple one-day locals and symposiums, Kaseya offers a can�t-miss event for everyone in the…

2 years ago

NICE Wins 2022 Best Practices Award for Technology Innovation Leadership in Asia-Pacific Market

Frost & Sullivan recognizes NICE for its industry-leading solutions that deliver efficient and smart AI-powered digital-first experiences HOBOKEN, N.J.--(BUSINESS WIRE)--#NICE--NICE…

2 years ago

Ubiquitome gets FDA authorization with Yale SARS-CoV-2 self-collection tests

NIH RADx winner�s next gen Liberty16 Pro gets EUA AUCKLAND, New Zealand--(BUSINESS WIRE)--#COVIDCATCHER--Ubiquitome�s next generation real time PCR device system,…

2 years ago

Kyocera Plans New Manufacturing Plant in Japan�s Nagasaki Prefecture by 2026

Company envisions up to 1,000 jobs in Isahaya City as other sites near full capacity KYOTO, JAPAN--(BUSINESS WIRE)--Kyocera Corporation (President:…

2 years ago

Dr. Reddy�s Successfully Completes Phase 1 Study of DRL_TC, a Proposed Biosimilar of Tocilizumab

Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate to severe active rheumatoid arthritis…

2 years ago

Introducing THE BRIJ – A World of Arts and Culture

Serendipity Arts announces THE BRIJ, a futuristic arts and culture centre in the National Capital Region that will host multiple…

2 years ago

Movers Buddy Reports Affordable Suburbs To Move To If You Want To Save On Rent In Melbourne And Sydney

MELBOURNE, Australia--(BUSINESS WIRE)--As rents continue to soar, Australian families are struggling more than ever before to find affordable housing. When…

2 years ago

Dongying seeks trade opportunities in overseas markets

DONGYING, China--(BUSINESS WIRE)--Dongying, a city in East China�s Shandong province, has been helping local enterprises expand in international markets as…

2 years ago

A Third of Businesses Predict the Current Inflationary Environment to Last More Than Two Years – Taulia

SAN FRANCISCO--(BUSINESS WIRE)--A third of global businesses predict the current inflationary environment to continue for more than two years, according…

2 years ago

ENHERTU� Recommended for Approval in the EU by CHMP for Patients with HER2 Low Metastatic Breast Cancer

Daiichi Sankyo and AstraZeneca�s ENHERTU is the first HER2 directed therapy to demonstrate a significant survival benefit versus chemotherapy in…

2 years ago